EGM
VYNE icon

Engineers Gate Manager’s VYNE Therapeutics VYNE Stock Holding History

Engineers Gate Manager’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,851
Closed -$34K – 2344
2021
Q4 		$34K Buy
+1,851
New +$39.7K ﹤0.01% 1906
2021
Q3 		– Sell
-874
Closed -$55K – 2008
2021
Q2 		$55K Sell
874
-490
-36% -$38.8K ﹤0.01% 1544
2021
Q1 		$168K Buy
1,364
+1,138
+504% +$165K 0.01% 1636
2020
Q4 		$26K Buy
226
+79
+54% +$9.93K ﹤0.01% 1648
2020
Q3 		$18K Sell
147
-229
-61% -$26.7K ﹤0.01% 1626
2020
Q2 		$47K Buy
+376
New +$50.9K ﹤0.01% 1643
2019
Q2 		– Sell
-260
Closed -$147K – 1396
2019
Q1 		$147K Buy
+260
New +$125K 0.01% 854

Other funds holding VYNE

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Engineers Gate Manager's VYNE Position: Q1 2022 in Review

Engineers Gate Manager sold out of VYNE Therapeutics (VYNE) in Q1 2022, closing a stake of 1,851 shares — an estimated $34K sold.

Engineers Gate Manager first reported a position in VYNE in Q1 2019 and held it in 7 quarters. The position peaked at $168K in Q1 2021. 44 funds tracked by Wall St. Rank hold VYNE as of Q1 2022.

  • Engineers Gate Manager reported no remaining VYNE Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 1,851 VYNE Therapeutics shares in Q1 2022, an estimated $34K.
  • Engineers Gate Manager first reported a position in VYNE Therapeutics in Q1 2019 and held it in 7 quarters.
  • Engineers Gate Manager's VYNE Therapeutics position peaked at $168K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.